TVTX
Travere Therapeutics, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +4.3% · posisi baru bersih 0.0% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q1 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1.17M | $68.91M | n/a | n/a |
| Q2 2026 | 114 | +17 | 68.21M | $3.64B | +21 | −4 |
| Q1 2026 | 100 | -5 | 69.82M | $2.07B | +9 | −14 |
| Q4 2025 | 104 | +1 | 74.66M | $2.85B | +1 | n/a |
| Q3 2025 | 21 | +1 | 36.01M | $860.71M | +2 | −2 |
| Q2 2025 | 18 | +1 | 30.33M | $448.83M | +2 | −1 |
| Q1 2025 | 14 | 0 | 16.78M | $300.70M | n/a | n/a |
| Q4 2024 | 14 | +1 | 16.09M | $280.22M | +2 | −1 |
| Q3 2024 | 12 | -1 | 7.80M | $109.09M | +1 | −2 |
| Q2 2024 | 13 | n/a | 10.32M | $84.85M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasif) | 3.65M | -3.2% | $65.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 2.70M | +12.2% | $48.43M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | Viking Global Investors ✦ | 2.60M | -10.3% | $46.63M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | Adage Capital Partners ✦ | 2.18M | +479.9% | $39.15M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasif) | 1.98M | +7.3% | $35.43M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 6 | D. E. Shaw & Co. ✦ | 1.71M | -24.8% | $30.71M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 7 | Two Sigma Investments ✦ | 768.79K | +10.9% | $13.78M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 524.34K | -9.5% | $9.40M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 9 | AQR Capital Management ✦ | 399.31K | -5.8% | $7.16M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 10 | Norges Bank ✦ (pasif) | 71.00K | 0.0% | $1.27M | 0.0% | Held | 4 | SEC ↗ |
| 11 | Millennium Management ✦ | 59.83K | -90.4% | $1.07M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 53.31K | +34.6% | $956,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 43.18K | 0.0% | $773,821 | 0.0% | Held | 4 | SEC ↗ |
| 14 | Wellington Management ✦ | 33.17K | -1.0% | $594,407 | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 121.20K saham, $3,600 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 78.40K lbr · $4.31M
Officer, Director · 37.27K lbr · $2.02M
Officer, Director · 128.06K lbr · $6.78M
Officer · 8.28K lbr · $538,917
Officer, Director · 101.69K lbr · $6.57M
Officer, Director · 6.80K lbr · $441,795
Officer, Director · 99.72K lbr · $6.31M
Officer · 79.11K lbr · $5.04M
Officer · 93.60K lbr · $5.92M
Officer, Director · 96.12K lbr · $6.12M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi